- Pharmaceutical companies
- Pierre Fabre
Pierre Fabre
Phone: +33 1 53 53 20 50
Web: https://www.pierre-fabre.com
| Type | Private limited company |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1951 (1951) |
| Headquarters | Paris, France |
| Area served | Worldwide |
| Key people |
|
| Number of employees | 13,000 (2015) (Homepage) |
| Website | www.pierre-fabre.com |
The Pierre Fabre Group is a pioneer on the French industrial scene. Why? A Foundation of the same name, recognized as being of public interest, has been the main Group shareholder since 2013. This unique shareholding structure guarantees the company's independence and helps us favor the longterm over the short term, in line with our founder's principles.
For detailed contact information visit location pages below.
Pierre Fabre's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Pierre Fabre
-
Pierre Fabre MedicamentPierre Fabre Pharma GmbHTerminado
-
Pierre Fabre Medical DevicesTerminado
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGReclutamientoMelanoma Etapa IV | Melanoma Etapa IIIAustria, Alemania, Suiza
-
Pierre Fabre MedicamentReclutamientoCáncer de pulmón de células no pequeñas (CPCNP)Taiwán, España, Francia, Países Bajos, Porcelana, Estados Unidos, Alemania
-
Pierre Fabre MedicamentTerminadoMelanoma metastásico | Melanoma (piel) | Mutación BRAF V600Portugal
-
Pierre Fabre MedicamentTerminadoArtrosis, RodillaPolonia
-
Pierre Fabre MedicamentTerminadoTumores sólidos avanzados o metastásicosFrancia, España
-
Pierre Fabre MedicamentTerminado
-
Pierre Fabre MedicamentTerminadoCáncer de mama | MetástasisFrancia, Ucrania, Reino Unido, Alemania, Taiwán, España, Bielorrusia, Bélgica, Portugal, Sudáfrica, Federación Rusa, Austria, Italia, Argentina
-
Pierre Fabre MedicamentTerminadoFibrilación auricularEspaña, Hungría, Italia, Polonia, Chequia